Anixa Biosciences (ANIX) Convertible Debt (2012 - 2014)
Anixa Biosciences' (ANIX) quarterly Convertible Debt came in at $1.8 million in Q3 2014, up 289.76% YoY from $450567.0 in Q3 2013, and up 7.9% on a QoQ basis from $1.6 million in Q2 2014.
Anixa Biosciences (ANIX) Convertible Debt (2012 - 2014) Analysis & Trends
Anixa Biosciences (ANIX) has 3 years of Convertible Debt data on file, last reported at $1.8 million in Q3 2014.
- Quarterly Convertible Debt rose 289.76% year-over-year to $1.8 million in Q3 2014, while the trailing twelve-month figure through Jul 2014 was $1.8 million (up 289.76% YoY) and the FY2013 annual result came in at $548598.0, up 1599.87% from the prior year.
- Convertible Debt improved to $1.8 million in Q3 2014, from $1.6 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $1.8 million in Q3 2014 to a low of $32273.0 in Q4 2012.
- A 3-year average of $843857.4 and a median of $501088.5 in 2013 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2013 — Convertible Debt jumped 1599.87% — and 2014, when it surged 258.81%.
- Tracing ANIX's Convertible Debt over 3 years: stood at $32273.0 in 2012, then jumped by 1599.87% to $548598.0 in 2013, then soared by 220.11% to $1.8 million in 2014.
- The last three Convertible Debt figures came in at $1.8 million (Q3 2014), $1.6 million (Q2 2014), and $1.5 million (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Anixa Biosciences | 121.44 Mn | 121.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2014 | 1.76 Mn |
| Apr 30, 2014 | 1.63 Mn |
| Jan 31, 2014 | 1.51 Mn |
| Oct 31, 2013 | 548,598.00 |
| Jul 31, 2013 | 450,567.00 |
| Apr 30, 2013 | 453,579.00 |
| Jan 31, 2013 | 370,181.00 |
| Oct 31, 2012 | 32,273.00 |